期刊文献+

玻璃酸钠治疗Ⅱ~Ⅲ阶段颞下颌关节紊乱综合症的疗效分析

Sodium Hyaluronate Treatment Phase Ⅱ~Ⅲ Temporomandibular Joint Disorder Syndrome Curative Effect Analysis
下载PDF
导出
摘要 目的研究玻璃酸钠、2%利多卡因注射液在治疗27例II^III阶段颞下颌关节紊乱综合症的临床效果分析;方法把27例患者任意分为22例实验组和5例对照组,前者采用玻璃酸钠1 m L(10 mg)、2%利多卡因0.5 m L行患侧关节上腔注射,后者用2%利多卡因1 m L、维生素B12500单位行关节上腔注射。结果治疗组有效率90.90%,对照组有效率40.00%,两组实验有明显差异。结果玻璃酸钠在治疗II^III阶段颞下颌关节紊乱综合症中效果显著。 Study of sodium hyaluronate,2% lidocaine injection in the treatment of the clinical effect of 27 cases of Ⅱ~Ⅲstage temporomandibular joint disorder syndrome analysis;specific methods:the 27 patients were arbitrarily divided into 22 cases of the experimental group and 5 cases in the control group,the former using 1ml sodium hyaluronate(10mg),2% lidocaine 0.5ml patients the injection side articular cavity,the latter with injection of 2% lidocaine 1ml,vitamin B12500 unit for articular cavity.Results:the effective rate of treatment group 95.45%,control group with an efficiency of 40%,two groups have obvious difference.Results:the effect of sodium hyaluronate in the treatment of Ⅱ~Ⅲ stage of temporomandibular joint disturbance syndrome significantly.
出处 《科技创新导报》 2014年第34期242-242,共1页 Science and Technology Innovation Herald
关键词 玻璃酸钠2%利多卡因注射液 关节上腔注射 颞下颌紊乱综合症 Sodium Hyaluronate 2% lidocaine Injection Intra-articular injection Temporomandibular Disorder Syndrome
  • 相关文献

参考文献4

二级参考文献25

  • 1谷志远.颞下颌关节紊乱病病因学研究[J].中国实用口腔科杂志,2009,2(3):129-131. 被引量:41
  • 2许卫华,马绪臣,郭传瑸,吴任刚.颞下颌关节紊乱病患者的症状自评量表调查[J].中华口腔医学杂志,2005,40(5):359-361. 被引量:23
  • 3马绪臣.口腔颌面医学影像诊断学[M].4版.北京:人民卫生出版社,2004:181-182.
  • 4史宗道,王晓娟.口腔临床药物学[M].北京:人民卫生出版社,2004:200.
  • 5Ohrbach R,Turner JA,Sherman JJ , et al. The research di-agnostic criteria for temporomandibular disorders. IV : e-valuation of psychometric properties of the axis II meas-ures[J].J Orofac Pain,2010,24(1) :48-62.
  • 6Ohrbach R. Assessment and further development of RDC/TMD Axis II biobehavioural instruments: a research pro-gramme progress report[J].J Oral Rehabil, 2010,37( 10):784-798.
  • 7Yap AU,Dworkin SF,Chua EK,et al. Prevalence of tem-poromandibular disorder subtypes, psychologic distress,and psychosocial dysfunction in Asian patients[J]. J Oro-fac Pain,2003,17(1) :21-28.
  • 8Manfredini D’Borella L, Favero L, et al. Chronic pain se-verity and depression/somatization levels in TMD patients[J].Int J Prosthodont,2010 ,23(6) : 529-534.
  • 9Pallegama RW? Ranasinghe AW, Weerasinghe VS, et al.Anxiety and personality traits in patients w ith muscle re-lated temporomandibular disorders [J].J Oral Rehabil,2005,32(10):701-707.
  • 10Casanova-Rosado JF,Medina-Solis CE,Vallejos-SanchezAA,et al. Prevalence and associated factors for tem-poromandibular disorders in a group of Mexican adoles-cents and youth adults[J].Clin Oral Investig,2006,10(1):42-49.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部